NYSE : MPT
Medical Properties Trust, Inc. — Key statistics
United States
Last price 2.25 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.34B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.30B |
| Enterprise Value | 9.96B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Sep 10, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 597.20M |
| Shares Outstanding | 597.16M |
| Shares Change (YoY) | -0.38% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 17.90% |
| Owned by Institutions (%) | 61.11% |
| Float | 489.92M |
Ratios
| Measure | Value |
|---|
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | 5.27 |
| Forward PE | n/a |
| PS Ratio | 1.19 |
| Forward PS | 1.24 |
| PB Ratio | 0.28 |
| P/TBV Ratio | 0.28 |
| P/FCF Ratio | 7.78 |
| P/OCF Ratio | 5.74 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 40.23 |
| EV / Sales | 9.14 |
| EV / EBITDA | 10.58 |
| EV / EBIT | 15.31 |
| EV / FCF | 59.57 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.59 |
| Quick Ratio | 4.88 |
| Debt / Equity | 2.00 |
| Debt / EBITDA | 9.82 |
| Debt / FCF | 55.37 |
| Interest Coverage | 1.17 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 5.40% |
| Return on Assets (ROA) | 2.77% |
| Return on Invested Capital (ROIC) | 4.63% |
| Return on Capital Employed (ROCE) | 4.65% |
| Weighted Average Cost of Capital (WACC) | 5.68% |
| Revenue Per Employee | $9.01M |
| Profits Per Employee | $2.05M |
| Employee Count | 121 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -4.21M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.49 |
| 52-Week Price Change | -57.83% |
| 50-Day Moving Average | 3.38 |
| 200-Day Moving Average | 4.54 |
| Relative Strength Index (RSI) | 18.33 |
| Average Volume (20 Days) | 18,010,914 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 149.42M |
| Short Previous Month | 145.30M |
| Short % of Shares Out | 25.02% |
| Short % of Float | 30.50% |
| Short Ratio (days to cover) | 11.74 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.09B |
| Gross Profit | 1.04B |
| Operating Income | 650.81M |
| Pretax Income | 246.28M |
| Net Income | 247.62M |
| EBITDA | 941.35M |
| EBIT | 650.81M |
| Earnings Per Share (EPS) | $0.41 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 599.28M |
| Total Debt | 9.26B |
| Net Cash | -8.66B |
| Net Cash Per Share | -$14.50 |
| Equity (Book Value) | 4.62B |
| Book Value Per Share | 7.74 |
| Working Capital | 1.83B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 226.82M |
| Capital Expenditures | -59.57M |
| Depreciation & Amortization | 276.64M |
| Net Borrowing | n/a |
| Free Cash Flow | 167.25M |
| FCF Per Share | $0.28 |
Margins
| Measure | Value |
|---|
| Gross Margin | 95.67% |
| Operating Margin | 59.70% |
| Pretax Margin | 22.59% |
| Profit Margin | 22.85% |
| EBITDA Margin | 86.35% |
| EBIT Margin | 59.70% |
| FCF Margin | 15.14% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.36 |
| Dividend Yield | 16.51% |
| Dividend Growth (YoY) | 12.50% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 87.01% |
| FCF Payout Ratio | 128.54% |
| Buyback Yield | 0.38% |
| Shareholder Yield | 16.89% |
| Earnings Yield | 18.98% |
| FCF Yield | 12.85% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $4.13 |
| Price Target Difference | 89.22% |
| Analyst Consensus | Hold |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 0.28% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |